Global Influenza Virus Vaccine (H1N1) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

SKU ID : QYR-18655628 | Publishing Date : 28-Jun-2021 | No. of pages : 116

Detailed TOC of Global Influenza Virus Vaccine (H1N1) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

1 Influenza Virus Vaccine (H1N1) Market Overview
    1.1 Influenza Virus Vaccine (H1N1) Product Overview
    1.2 Influenza Virus Vaccine (H1N1) Market Segment by Type
        1.2.1 Intramuscular Vaccine
        1.2.2 Nasal Spray Vaccine
    1.3 Global Influenza Virus Vaccine (H1N1) Market Size by Type
        1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Overview by Type (2016-2027)
        1.3.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size Review by Type (2016-2021)
            1.3.2.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume by Type (2016-2021)
            1.3.2.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value by Type (2016-2021)
            1.3.2.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021)
        1.3.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Type (2022-2027)
            1.3.3.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume by Type (2022-2027)
            1.3.3.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value by Type (2022-2027)
            1.3.3.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2022-2027)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        1.4.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        1.4.3 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        1.4.4 Latin America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        1.4.5 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)

2 Global Influenza Virus Vaccine (H1N1) Market Competition by Company
    2.1 Global Top Players by Influenza Virus Vaccine (H1N1) Sales (2016-2021)
    2.2 Global Top Players by Influenza Virus Vaccine (H1N1) Revenue (2016-2021)
    2.3 Global Top Players Influenza Virus Vaccine (H1N1) Price (2016-2021)
    2.4 Global Top Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
        2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate (2016-2021)
        2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Virus Vaccine (H1N1) Sales and Revenue in 2020
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
    2.7 Date of Key Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
    2.8 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Offered
    2.9 Mergers & Acquisitions, Expansion

3 Influenza Virus Vaccine (H1N1) Status and Outlook by Region
    3.1 Global Influenza Virus Vaccine (H1N1) Market Size and CAGR by Region: 2016 VS 2021 VS 2026
    3.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Region
        3.2.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2021)
        3.2.2 Global Influenza Virus Vaccine (H1N1) Sales in Value by Region (2016-2021)
        3.2.3 Global Influenza Virus Vaccine (H1N1) Sales (Volume & Value) Price and Gross Margin (2016-2021)
    3.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Region
        3.3.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2022-2027)
        3.3.2 Global Influenza Virus Vaccine (H1N1) Sales in Value by Region (2022-2027)
        3.3.3 Global Influenza Virus Vaccine (H1N1) Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Influenza Virus Vaccine (H1N1) by Application
    4.1 Influenza Virus Vaccine (H1N1) Market Segment by Application
        4.1.1 3 To 10 Years Old
        4.1.2 10 To 18 Years Old
        4.1.3 Above 18 Years Old
        4.1.4 Other
    4.2 Global Influenza Virus Vaccine (H1N1) Market Size by Application
        4.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Overview by Application (2016-2027)
        4.2.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size Review by Application (2016-2021)
            4.2.2.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume, by Application (2016-2021)
            4.2.2.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value, by Application (2016-2021)
            4.2.2.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Application (2016-2021)
        4.2.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Application (2022-2027)
            4.2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume, by Application (2022-2027)
            4.2.3.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value, by Application (2022-2027)
            4.2.3.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Application (2022-2027)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        4.3.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        4.3.3 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        4.3.4 Latin America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        4.3.5 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)

5 North America Influenza Virus Vaccine (H1N1) by Country
    5.1 North America Influenza Virus Vaccine (H1N1) Historic Market Size by Country
        5.1.1 North America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021)
        5.1.2 North America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021)
    5.2 North America Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country
        5.2.1 North America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027)
        5.2.2 North America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027)

6 Europe Influenza Virus Vaccine (H1N1) by Country
    6.1 Europe Influenza Virus Vaccine (H1N1) Historic Market Size by Country
        6.1.1 Europe Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021)
        6.1.2 Europe Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021)
    6.2 Europe Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country
        6.2.1 Europe Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027)
        6.2.2 Europe Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027)

7 Asia-Pacific Influenza Virus Vaccine (H1N1) by Region
    7.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Historic Market Size by Region
        7.1.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2021)
        7.1.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Value by Region (2016-2021)
    7.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Forecasted Market Size by Region
        7.2.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2022-2027)
        7.2.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Value by Region (2022-2027)

8 Latin America Influenza Virus Vaccine (H1N1) by Country
    8.1 Latin America Influenza Virus Vaccine (H1N1) Historic Market Size by Country
        8.1.1 Latin America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021)
        8.1.2 Latin America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021)
    8.2 Latin America Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country
        8.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027)
        8.2.2 Latin America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027)

9 Middle East and Africa Influenza Virus Vaccine (H1N1) by Country
    9.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Historic Market Size by Country
        9.1.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021)
        9.1.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021)
    9.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country
        9.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027)
        9.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business
    10.1 CSL
        10.1.1 CSL Corporation Information
        10.1.2 CSL Introduction and Business Overview
        10.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
        10.1.5 CSL Recent Development
    10.2 NVS(Novartis)
        10.2.1 NVS(Novartis) Corporation Information
        10.2.2 NVS(Novartis) Introduction and Business Overview
        10.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.2.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
        10.2.5 NVS(Novartis) Recent Development
    10.3 Sanofi Pasteur
        10.3.1 Sanofi Pasteur Corporation Information
        10.3.2 Sanofi Pasteur Introduction and Business Overview
        10.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
        10.3.5 Sanofi Pasteur Recent Development
    10.4 Medimmune
        10.4.1 Medimmune Corporation Information
        10.4.2 Medimmune Introduction and Business Overview
        10.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
        10.4.5 Medimmune Recent Development
    10.5 GSK
        10.5.1 GSK Corporation Information
        10.5.2 GSK Introduction and Business Overview
        10.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
        10.5.5 GSK Recent Development
    10.6 Baxter
        10.6.1 Baxter Corporation Information
        10.6.2 Baxter Introduction and Business Overview
        10.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
        10.6.5 Baxter Recent Development
    10.7 Beijing Kexing Bio-Vaccine
        10.7.1 Beijing Kexing Bio-Vaccine Corporation Information
        10.7.2 Beijing Kexing Bio-Vaccine Introduction and Business Overview
        10.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
        10.7.5 Beijing Kexing Bio-Vaccine Recent Development
    10.8 Hualan Bio-Vaccine
        10.8.1 Hualan Bio-Vaccine Corporation Information
        10.8.2 Hualan Bio-Vaccine Introduction and Business Overview
        10.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
        10.8.5 Hualan Bio-Vaccine Recent Development
    10.9 Changchun Changsheng Bio-Technology
        10.9.1 Changchun Changsheng Bio-Technology Corporation Information
        10.9.2 Changchun Changsheng Bio-Technology Introduction and Business Overview
        10.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
        10.9.5 Changchun Changsheng Bio-Technology Recent Development
    10.10 Beijing Tiantan Bio-Products
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Influenza Virus Vaccine (H1N1) Product Category, Application and Specification
        10.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2016-2021)
        10.10.4 Main Business Overview
        10.10.5 Beijing Tiantan Bio-Products Recent Development
    10.11 Jiangsu Yanshen Bio-Technology
        10.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
        10.11.2 Jiangsu Yanshen Bio-Technology Introduction and Business Overview
        10.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
        10.11.5 Jiangsu Yanshen Bio-Technology Recent Development
    10.12 Zhejiang Tianyuan Bio-Pharmaceutical
        10.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
        10.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Introduction and Business Overview
        10.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
        10.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
    10.13 Dalian Yalifeng Bio-Pharmaceutical
        10.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
        10.13.2 Dalian Yalifeng Bio-Pharmaceutical Introduction and Business Overview
        10.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
        10.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
    10.14 Sinopharm
        10.14.1 Sinopharm Corporation Information
        10.14.2 Sinopharm Introduction and Business Overview
        10.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        10.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Products Offered
        10.14.5 Sinopharm Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Influenza Virus Vaccine (H1N1) Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
    11.4 Influenza Virus Vaccine (H1N1) Market Dynamics
        11.4.1 Industry Trends
        11.4.2 Market Drivers
        11.4.3 Market Challenges
        11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Influenza Virus Vaccine (H1N1) Distributors
    12.3 Influenza Virus Vaccine (H1N1) Downstream Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
            14.1.1.1 Research Programs/Design
            14.1.1.2 Market Size Estimation
            14.1.1.3 Market Breakdown and Data Triangulation
        14.1.2 Data Source
            14.1.2.1 Secondary Sources
            14.1.2.2 Primary Sources
    14.2 Author Details
    14.3 Disclaimer

List of Figures, Tables and Charts Available in Global Influenza Virus Vaccine (H1N1) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

List of Tables
    Table 1. Major Company of Intramuscular Vaccine
    Table 2. Major Company of Nasal Spray Vaccine
    Table 3. Global Influenza Virus Vaccine (H1N1) Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
    Table 4. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2016-2021)
    Table 6. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US& Million)
    Table 7. Global Influenza Virus Vaccine (H1N1) Market Share in Value by Type (2016-2021)
    Table 8. Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021) & (US$/Dose)
    Table 9. Global Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 10. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2022-2027)
    Table 11. Global Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (US$ Million)
    Table 12. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2022-2027)
    Table 13. Global Influenza Virus Vaccine (H1N1) Price by Type (2022-2027) & (US$/Dose)
    Table 14. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 15. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million)
    Table 16. Europe Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 17. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million)
    Table 18. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 19. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million)
    Table 20. Latin America Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 21. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million)
    Table 22. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 23. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million)
    Table 24. Global Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021) & (K Doses)
    Table 25. Global Influenza Virus Vaccine (H1N1) Sales Share by Company (2016-2021)
    Table 26. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 27. Global Influenza Virus Vaccine (H1N1) Revenue Share by Company (2016-2021)
    Table 28. Global Market Influenza Virus Vaccine (H1N1) Price by Company (2016-2021) & (US$/Dose)
    Table 29. Global Influenza Virus Vaccine (H1N1) Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020
    Table 32. Date of Key Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
    Table 33. Key Manufacturers Influenza Virus Vaccine (H1N1) Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Influenza Virus Vaccine (H1N1) Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
    Table 36. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses)
    Table 37. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2016-2021)
    Table 38. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (US$ Million)
    Table 39. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2016-2021)
    Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 41. Global Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (K Doses)
    Table 42. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2022-2027)
    Table 43. Global Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (US$ Million)
    Table 44. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2022-2027)
    Table 45. Global Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2022-2027)
    Table 46. Global Influenza Virus Vaccine (H1N1) Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
    Table 47. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 48. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2016-2021)
    Table 49. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 50. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2016-2021)
    Table 51. Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) & (US$/Dose)
    Table 52. Global Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 53. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2022-2027)
    Table 54. Global Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (US$ Million)
    Table 55. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2022-2027)
    Table 56. Global Influenza Virus Vaccine (H1N1) Price by Application (2022-2027) & (US$/Dose)
    Table 57. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
    Table 58. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 59. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Table 60. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
    Table 61. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 62. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Table 63. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
    Table 64. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 65. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Table 66. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
    Table 67. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 68. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Table 69. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
    Table 70. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million)
    Table 71. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Table 72. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 73. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021)
    Table 74. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million)
    Table 75. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021)
    Table 76. North America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses)
    Table 77. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027)
    Table 78. North America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million)
    Table 79. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027)
    Table 80. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 81. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021)
    Table 82. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million)
    Table 83. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021)
    Table 84. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses)
    Table 85. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027)
    Table 86. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million)
    Table 87. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027)
    Table 88. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses)
    Table 89. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2016-2021)
    Table 90. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (US$ Million)
    Table 91. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2016-2021)
    Table 92. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (K Doses)
    Table 93. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2022-2027)
    Table 94. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (US$ Million)
    Table 95. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2022-2027)
    Table 96. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 97. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021)
    Table 98. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million)
    Table 99. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021)
    Table 100. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses)
    Table 101. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027)
    Table 102. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million)
    Table 103. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027)
    Table 104. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 105. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021)
    Table 106. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million)
    Table 107. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021)
    Table 108. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses)
    Table 109. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027)
    Table 110. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million)
    Table 111. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027)
    Table 112. CSL Corporation Information
    Table 113. CSL Introduction and Business Overview
    Table 114. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 115. CSL Influenza Virus Vaccine (H1N1) Product
    Table 116. CSL Recent Development
    Table 117. NVS(Novartis) Corporation Information
    Table 118. NVS(Novartis) Introduction and Business Overview
    Table 119. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 120. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product
    Table 121. NVS(Novartis) Recent Development
    Table 122. Sanofi Pasteur Corporation Information
    Table 123. Sanofi Pasteur Introduction and Business Overview
    Table 124. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 125. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product
    Table 126. Sanofi Pasteur Recent Development
    Table 127. Medimmune Corporation Information
    Table 128. Medimmune Introduction and Business Overview
    Table 129. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 130. Medimmune Influenza Virus Vaccine (H1N1) Product
    Table 131. Medimmune Recent Development
    Table 132. GSK Corporation Information
    Table 133. GSK Introduction and Business Overview
    Table 134. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 135. GSK Influenza Virus Vaccine (H1N1) Product
    Table 136. GSK Recent Development
    Table 137. Baxter Corporation Information
    Table 138. Baxter Introduction and Business Overview
    Table 139. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 140. Baxter Influenza Virus Vaccine (H1N1) Product
    Table 141. Baxter Recent Development
    Table 142. Beijing Kexing Bio-Vaccine Corporation Information
    Table 143. Beijing Kexing Bio-Vaccine Introduction and Business Overview
    Table 144. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 145. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 146. Beijing Kexing Bio-Vaccine Recent Development
    Table 147. Hualan Bio-Vaccine Corporation Information
    Table 148. Hualan Bio-Vaccine Introduction and Business Overview
    Table 149. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 150. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 151. Hualan Bio-Vaccine Recent Development
    Table 152. Changchun Changsheng Bio-Technology Corporation Information
    Table 153. Changchun Changsheng Bio-Technology Introduction and Business Overview
    Table 154. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 155. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 156. Changchun Changsheng Bio-Technology Recent Development
    Table 157. Beijing Tiantan Bio-Products Corporation Information
    Table 158. Beijing Tiantan Bio-Products Introduction and Business Overview
    Table 159. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 160. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product
    Table 161. Beijing Tiantan Bio-Products Recent Development
    Table 162. Jiangsu Yanshen Bio-Technology Corporation Information
    Table 163. Jiangsu Yanshen Bio-Technology Introduction and Business Overview
    Table 164. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 165. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 166. Jiangsu Yanshen Bio-Technology Recent Development
    Table 167. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    Table 168. Zhejiang Tianyuan Bio-Pharmaceutical Introduction and Business Overview
    Table 169. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 170. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 171. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
    Table 172. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    Table 173. Dalian Yalifeng Bio-Pharmaceutical Introduction and Business Overview
    Table 174. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 175. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 176. Dalian Yalifeng Bio-Pharmaceutical Recent Development
    Table 177. Sinopharm Corporation Information
    Table 178. Sinopharm Introduction and Business Overview
    Table 179. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 180. Sinopharm Influenza Virus Vaccine (H1N1) Product
    Table 181. Sinopharm Recent Development
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Influenza Virus Vaccine (H1N1) Market Trends
    Table 185. Influenza Virus Vaccine (H1N1) Market Drivers
    Table 186. Influenza Virus Vaccine (H1N1) Market Challenges
    Table 187. Influenza Virus Vaccine (H1N1) Market Restraints
    Table 188. Influenza Virus Vaccine (H1N1) Distributors List
    Table 189. Influenza Virus Vaccine (H1N1) Downstream Customers
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Virus Vaccine (H1N1) Product Picture
    Figure 2. Global Influenza Virus Vaccine (H1N1) Market Size, 2016 VS 2021 VS 2027 (US$ Million)
    Figure 3. Global Influenza Virus Vaccine (H1N1) Market Size Status and Outlook (2016-2027) & (US$ Million)
    Figure 4. Global Influenza Virus Vaccine (H1N1) Sales Status and Outlook (2016-2027) & (K Doses)
    Figure 5. Product Picture of Intramuscular Vaccine
    Figure 6. Global Intramuscular Vaccine Sales YoY Growth (2016-2021) & (K Doses)
    Figure 7. Product Picture of Nasal Spray Vaccine
    Figure 8. Global Nasal Spray Vaccine Sales YoY Growth (2016-2021) & (K Doses)
    Figure 9. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2027) & (US$ Million)
    Figure 10. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2016-2021)
    Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2016-2021)
    Figure 12. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2022-2027)
    Figure 13. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2022-2027)
    Figure 14. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020
    Figure 15. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020
    Figure 16. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020
    Figure 17. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020
    Figure 18. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020
    Figure 19. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020
    Figure 20. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020
    Figure 21. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020
    Figure 22. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020
    Figure 23. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vaccine (H1N1) Sales in 2020
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2020
    Figure 26. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 27. Product Picture of 3 To 10 Years Old
    Figure 28. Global 3 To 10 Years Old Sales YoY Growth (2016-2027) & (K Doses)
    Figure 29. Product Picture of 10 To 18 Years Old
    Figure 30. Global 10 To 18 Years Old Sales YoY Growth (2016-2027) & (K Doses)
    Figure 31. Product Picture of Above 18 Years Old
    Figure 32. Global Above 18 Years Old Sales YoY Growth (2016-2027) & (K Doses)
    Figure 33. Product Picture of Other
    Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Doses)
    Figure 35. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2027) & (US$ Million)
    Figure 36. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2016-2021)
    Figure 37. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2016-2021)
    Figure 38. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2022-2027)
    Figure 39. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application in 2020
    Figure 40. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Figure 41. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020
    Figure 42. Key Raw Materials Price
    Figure 43. Influenza Virus Vaccine (H1N1) Manufacturing Cost Structure
    Figure 44. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed

Keyplayers in Global Influenza Virus Vaccine (H1N1) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]